Literature DB >> 9554976

Mecamylamine selectively blocks nicotinic receptors on vasomotor sympathetic C neurons.

W X Shen1, J P Horn.   

Abstract

Mecamylamine differentially blocked fast nicotinic transmission in two functional subsets of sympathetic neurons within lumbar paravertebral ganglia of the bullfrog. EC50s for inhibition of postsynaptic compound action potentials were 27.3+/-2.5 microM in the secretomotor B system and 5.7+/-0.7 microM in the vasomotor C system. This 5.2:1 selectivity is 2.6 times greater than observed previously with d-tubocurarine, a nonselective blocker of nicotinic receptors, and it indicates that mecamylamine preferentially interacts with nicotinic receptors on sympathetic C neurons. We tested this by analyzing the effect of mecamylamine upon synaptic currents. In both cell types, the drug produced a qualitatively similar picture of open-channel blockade. It reduced EPSC amplitude, speeded EPSC decay, and became more effective with membrane hyperpolarization and repetitive activity. Despite these similarities, 8 microM mecamylamine reduced EPSC amplitude to a greater extent in C neurons, and the rate constant for drug binding to open channels was 4.4 times greater in B cells, irrespective of membrane potential. This implies that the unblocking rate for mecamylamine is much slower in C cells than B cells, and it shows that the drug recognizes a structural difference between nicotinic receptors on these two populations of sympathetic neurons. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9554976     DOI: 10.1016/s0006-8993(97)01520-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

Review 1.  Potential therapeutic uses of mecamylamine and its stereoisomers.

Authors:  Justin R Nickell; Vladimir P Grinevich; Kiran B Siripurapu; Andrew M Smith; Linda P Dwoskin
Journal:  Pharmacol Biochem Behav       Date:  2013-04-18       Impact factor: 3.533

2.  Mechanisms of the inhibition of endplate acetylcholine receptors by antiseptic chlorhexidine (experiments and models).

Authors:  A R Shaihutdinova; E E Nikolsky; F Vyskocil; A I Skorinkin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-10-06       Impact factor: 3.000

3.  Modeling study of mecamylamine block of muscle type acetylcholine receptors.

Authors:  Konstantin Ostroumov; Asya Shaikhutdinova; Andrey Skorinkin
Journal:  Eur Biophys J       Date:  2007-10-16       Impact factor: 1.733

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.